Biodesix Inc (BDSX) Stock: A Year of Decreases and Increases

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Biodesix Inc’s current trading price is -80.37% away from its 52-week high, while its distance from the 52-week low is 133.12%. The stock’s price range for this period has been between $0.17 and $2.04 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 1.11 million for the day, a number notably lower than the average daily volume of 9.15 million over the last three months.

The stock of Biodesix Inc (BDSX) is currently priced at $0.4. In the last session, the stock climbed significantly, topping out at $2.0 after opening at $0.4. The day’s lowest price was $1.5 before the stock closed at $0.45.

The market performance of Biodesix Inc’s stock has been turbulent in recent times.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Biodesix Inc (BDSX) has experienced a quarterly rise of 15.15% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 58.73M and boasts a workforce of 273 employees.

Biodesix Inc: What Analysts Are Saying

As of right now, 4 analysts are rating Biodesix Inc as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 1 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.4250, with a change in price of -0.3494. Similarly, Biodesix Inc recorded 5,911,253 in trading volume during the last 100 days, posting a change of -46.59%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for BDSX stands at 63.28. Similarly, the long-term debt-to-equity ratio is also 62.18.

BDSX Stock Stochastic Average

Biodesix Inc’s raw stochastic average for the past 50 days is presently 67.19%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 59.70%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 66.28% and 68.16%, respectively.

BDSX Stock Price Performance Analysis

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. The metric has seen a significant loss of -74.81% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -61.49%. Over the past 30 days, the price of BDSX has fallen by 31.14%. And in the last five days, it has surged by 10.27%.

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.